Turmeric

Names and identification

Language	Name
English	Turmeric
Common Names	Turmeric, Haldi, Indian Saffron
Hindi	Haldi
Sanskrit	Haridra, Gauri, Kanchani
Latin/Botanical	Curcuma longa

Parts Used

• Rhizome

Dosha Effects

Dosha	Effect
Vata	Decreases
Kapha	Decreases
Pitta	Neutral (Decreases In Moderation)

Key Phytochemical Constituents

• Curcumin (diferuloylmethane)
• Demethoxycurcumin
• Bisdemethoxycurcumin
• Turmerone
• Ar-turmerone

Therapeutic Actions (Karma)

• Anti-inflammatory (potent COX-2 inhibitor)
• Antioxidant
• Hepatoprotective
• Anti-cancer (preclinical)
• Wound healing
• Anti-microbial
• Digestive

How does it work?

• Primary: Inhibition of NF-kB signaling by preventing IkB-alpha degradation and reducing phosphorylation of NF-kB subunits p65 and p50.
• NLRP3 inflammasome: Curcumin hinders activation of the NLRP3 inflammasome through NF-kB pathway modulation.
• JAK/STAT pathway: Reduces JAK1/2 and STAT1/3 phosphorylation, inhibiting pro-inflammatory factor expression.
• MAPK/ERK cascade: Regulates mitogen-activated protein kinase extracellular signal-regulated kinase phosphorylation.
• p38 MAPK: Therapeutic modulation of p38 MAPK pathway with implications for chronic inflammatory diseases.
• Broad molecular targets: Inhibits NF-kB, AP-1, STAT3, Akt, Bcl-2, Bcl-XL, caspases, PARP, IKK, EGFR, HER2, JNK, MAPK, COX2, and 5-LOX.
• Diabetes: Targets TNF-alpha and IL-6 through NF-kB modulation; improves insulin sensitivity.
• Antioxidant: Activates Nrf2/ARE signaling pathway for cellular antioxidant defense.

How is it used traditionally?

Used widely in Ayurvedic formulations. Sacred in Hindu rituals. Classified as Varnya (complexion-enhancing), Kushthagna (anti-dermatosis), and Vishaghna (antitoxic). Golden milk (Haldi Doodh) is a traditional preparation.

Where is it described in the classical texts?

• Charaka Samhita
• Sushruta Samhita
• Bhavaprakasha Nighantu
• Ashtanga Hridaya

What do recent studies show?

• Jafari A, Abbastabar M, Alaghi A and others 2024. Curcumin on Human Health: A Comprehensive Systematic Review and Meta-Analysis of 103 Randomized Controlled Trials. Phytotherapy research : PTR. PMID 39478418 · doi:10.1002/ptr.8340
  103 RCTs covering 42 outcomes in 7,216 participants. High-credibility evidence for improvements in fasting blood sugar, CRP, HDL cholesterol, and body weight.
• Liu AJ, Wu PC, Chen YP and others 2025. Effects of curcumin and Curcuma longa extract on inflammatory biomarkers in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE): a systematic review and meta-analysis of randomized controlled trials. Inflammation research : official journal of the European Histamine Research Society … [et al.]. PMID 41372521 · doi:10.1007/s00011-025-02135-z
  Curcuma longa significantly attenuated systemic inflammation, lowering C-reactive protein and TNF-alpha in rheumatoid arthritis and systemic lupus erythematosus patients.
• Zeng L, Yang T, Yang K and others 2022. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial. Frontiers in immunology. PMID 35935936 · doi:10.3389/fimmu.2022.891822
  29 RCTs with 2,396 participants across 5 types of arthritis showed curcumin improved inflammation and pain levels with acceptable safety profile.
• Kehinde SA, Qaisrani ZN, Pattanayaiying R and others 2025. Clinical Potential of Curcuma longa Linn. as Nutraceutical/Dietary Supplement for Metabolic Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Foods (Basel, Switzerland). PMID 41517125 · doi:10.3390/foods15010060
  Curcumin significantly reduced fasting blood sugar, HbA1c, triglycerides, and LDL while elevating HDL and total antioxidant capacity in metabolic syndrome patients.
• Xu Q, Lian H, Zhou R and others 2025. Curcumin and multiple health outcomes: critical umbrella review of intervention meta-analyses. Frontiers in pharmacology. PMID 40538540 · doi:10.3389/fphar.2025.1601204
  Umbrella review synthesizing multiple meta-analyses confirmed broad therapeutic benefits but emphasized need for improved scientific quality in published studies.
• Yuan J, Pi C, Shen H and others 2025. Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic review of mechanistic and clinical evidence. Frontiers in pharmacology. PMID 40918536 · doi:10.3389/fphar.2025.1638645
  15 RCTs with 1,123 participants showed curcumin has potential benefits for depression and anxiety symptoms in patients with chronic diseases.

Recent safety updates

• Hepatotoxicity is an emerging concern: DILIN (Drug-Induced Liver Injury Network) reported 10 cases of turmeric-associated liver injury with latency of 1-4 months.
• Bioavailability enhancers (piperine/black pepper) increase risk: 20 mg piperine increases curcumin bioavailability 20-fold, and enhanced formulations are linked to greater liver injury risk.
• Liver injury features: Marked aminotransferase elevations (often >1000 U/L) with hepatocellular pattern; autoantibodies may develop.
• Genetic susceptibility identified: HLA-B*35:01 allele found in 7/10 DILIN patients, previously linked to green tea hepatotoxicity.
• Recovery: Generally rapid after discontinuation; prednisone used in severe cases but may not be necessary.
• Turmeric-induced liver injury reported in combination with semaglutide (2024 case report).
• Drug interactions: May interact with blood thinners (anticoagulants/antiplatelets), diabetes medications, and drugs metabolized by CYP3A4, CYP1A2, and CYP2B6.
• GI side effects at high doses: nausea, diarrhea, and abdominal discomfort.

Recommended Dosage

Powder: 1-3g/day; Curcumin extract: 500-2000mg/day

Safety, contraindications and cautions

• Gallstones (stimulates bile)
• Blood thinners (anticoagulant synergy)
• Pre-surgery
• Iron-deficiency anemia (may reduce iron absorption)

What is it made of?

Part(s) Analyzed: Rhizome

Curcuminoids

• Curcumin (2-8%)
• Demethoxycurcumin (1-2%)
• Bisdemethoxycurcumin (0.5-1%)

Sesquiterpenoids

• Ar-turmerone (25-30% of essential oil)
• Alpha-turmerone
• Beta-turmerone
• Zingiberene

Phenolic Acids

• Ferulic acid
• Caffeic acid
• Vanillic acid

Essential Oil Composition

• Ar-turmerone: 25-30%
• Alpha-turmerone: 15-20%
• Beta-turmerone: 10-15%
• Zingiberene: 5-10%
• 1,8-Cineole: 2-5%
• Alpha-phellandrene: 1-3%

Dosage forms and preparation

Dosage Forms: Churna (powder), Capsule, Tablet, Softgel (curcumin + oil), Kwatha (decoction), Paste (Lepa), Haldi Doodh (golden milk), Nanoparticle formulation, Phytosome complex, Liposomal formulation

Standard Dosage: 1-3 g turmeric powder daily with food; 250-500 mg standardized curcumin extract (95%) twice daily; up to 8 g/day in clinical trials

Optimal Timing: With meals containing fat for enhanced absorption; avoid taking with antacids (alkaline pH degrades curcumin)

Storage: Store in airtight, light-resistant containers at 15-25 deg C. Curcumin is extremely photosensitive; opaque packaging mandatory. Protect from alkaline environments. Phytosome/lipid formulations may require refrigeration (2-8 deg C) for optimal stability.

Marker Compounds: Curcumin (diferuloylmethane), Demethoxycurcumin, Bisdemethoxycurcumin, ar-Turmerone, alpha-Turmerone, beta-Turmerone, Curcumol, Zingiberene

Synergistic Combinations

• Piperine (from Maricha/Pippali) - classical bioenhancer, 20x curcumin bioavailability
• Boswellia serrata - synergistic anti-inflammatory (joint health formulations)
• Ashwagandha - adaptogenic and anti-inflammatory synergy
• Quercetin - synergistic antioxidant and anti-inflammatory
• Ginger (Shunthi) - complementary anti-inflammatory via COX/LOX pathways
• Turmeric essential oil (ar-turmerone) - enhances curcumin absorption and has independent anti-inflammatory activity